RAP 0.00% 20.5¢ resapp health limited

Ann: Half Yearly Report and Accounts, page-53

  1. 4,921 Posts.
    lightbulb Created with Sketch. 4984
    If the technology is really so cutting edge, how have they diddled away with such a big cash burn, next to no revenue, and an increasing list of non-material partnerships, all during a global respiratory pandemic? This should have been their ticket to success, and it’s been wasted.

    Unfortunately, on financials, this thing looks hugely overvalued at $60M. 2022 is going to be tough for many companies at this end of the market.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.